Cascadian Therapeutics, Inc. Employee Directory
Biotechnology ResearchWashington, United States11-50 Employees
Cascadian Therapeutics, Inc. operates as a clinical-stage biotechnology company focused on developing cancer therapies. Its pipeline centers on discovering and advancing novel compounds to improve patient outcomes, led by ONT-380, a small-molecule HER2 inhibitor that is orally active and selective. The company is headquartered in Seattle, Washington, and maintains a small-to-mid-sized team. In addition to its internal programs, Cascadian pursues collaborations to support discovery efforts, including a partnership with Adimab, LLC to identify antibodies for oncology targets. The organization’s work is anchored in cancer treatment within the biotechnology research field, and it is based in Seattle.